Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: Nov 15, 2024 · CIK: 728387

Sentiment: neutral

Topics: regulatory-filing, sec-filing

TL;DR

Perspective Therapeutics filed an 8-K on 11/15/24, check for updates.

AI Summary

Perspective Therapeutics, Inc. filed an 8-K on November 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington. This filing does not contain specific financial figures or event details beyond its classification.

Why It Matters

This 8-K filing indicates that Perspective Therapeutics, Inc. has submitted required regulatory documentation to the SEC, which may contain updates on company events or financial information.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate disclosed material events or financial impacts.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Perspective Therapeutics, Inc. in this 8-K filing?

The provided text of the 8-K filing does not specify the details of the 'Other Events' beyond listing it as an item information.

What is the significance of filing 'Financial Statements and Exhibits' in this 8-K?

Filing 'Financial Statements and Exhibits' indicates that the company is providing updated financial information or relevant supporting documents as required by the SEC.

When was Perspective Therapeutics, Inc. previously known as Isoray, Inc.?

The filing indicates that the company's name was changed from Isoray, Inc. on December 31, 2018.

Where are the principal executive offices of Perspective Therapeutics, Inc. located?

The principal executive offices of Perspective Therapeutics, Inc. are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington, 98121.

What is the Commission File Number for Perspective Therapeutics, Inc.?

The Commission File Number for Perspective Therapeutics, Inc. is 001-33407.

Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2024-11-15 07:30:29

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On November 15, 2024, Perspective Therapeutics, Inc. posted an updated corporate presentation on its website at www.perspectivetherapeutics.com. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Corporate Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: November 15, 2024 By: /s/ Johan (Thijs) Spoor Johan (Thijs) Spoor, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing